All In Biotech

Drug Trial Radar · NCT06489015

Recombinant Human Serum Albumin in the Treatment of Mild-to-moderate AD (Alzheimer's Disease) Exploratory Clinical Trial

An Open-label, Parallel-group Exploratory Clinical Trial to Evaluate the Safety and Preliminary Efficacy of Recombinant Human Serum Albumin Injection in the Treatment of Mild-to-moderate Alzheimer's Disease

Last checked: Nov 20, 2026Latest source record: Aug 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

30

Actual

Start

Aug 27, 2024

Primary completion

Apr 14, 2026

Study completion Apr 14, 2026

Sponsor

Lead sponsor
Shenzhen Protgen Co., Ltd.Industry
Sponsor type
Industry
First posted
Jul 5, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Early phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 50 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This clinical trial is an open-label, parallel-group, exploratory study of recombinant human serum albumin in patients with mild to moderate Alzheimer's Disease (AD).

Conditions

  • Alzheimer's Disease (AD)

Interventions

  • Recombinant Human Serum AlbuminDrug

    Each group receives the investigational drug (recombinant human serum albumin), with the distinction being the variation in dosing.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse EventsTime frame: About week 29 or 41(It depends on whether the participant enters the extention treatment period)

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Luoyang Third People's Hospital

    Luoyang, Henan, China

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China

  • Wuhan Union Hospital of China

    Wuhan, Hubei, China

  • Clinical Medical College & Affiliated Hospital Of Jiujiang University

    Jiujiang, Jiangxi, China

  • Shanghai Mental Health Center

    Shanghai, Shanghai Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.